Inspire Medical Systems INSP
$ 188.28
1.54%
Quarterly report 2024-Q3
added 11-04-2024
Inspire Medical Systems Balance Sheet 2011-2024 | INSP
Annual Balance Sheet Inspire Medical Systems
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-433 M | -205 M | -166 M | 128 M | 18.6 M | 7.5 M | 9.01 M | - | - | - | - | - | |
Long Term Debt |
24.8 M | 7.54 M | 8.8 M | 24.7 M | 24.5 M | 24.9 M | 16.5 M | 12.4 M | - | - | - | - | - |
Long Term Debt Current |
- | 1.34 M | 312 K | - | 828 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 24.6 M | 24.9 M | 16.5 M | 12.4 M | - | - | - | - | - |
Total Current Liabilities |
78.1 M | 61.2 M | 41.3 M | 20.7 M | 16.9 M | 11.2 M | - | - | - | - | - | - | - |
Total Liabilities |
104 M | 68.9 M | 66 M | 51.4 M | 41.4 M | 36.1 M | 23.6 M | 19.7 M | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-345 M | -324 M | -279 M | -237 M | -180 M | -147 M | -125 M | -108 M | - | - | - | - | - |
Total Assets |
677 M | 565 M | 295 M | 281 M | 181 M | 200 M | 25.1 M | 13.1 M | - | - | - | - | - |
Cash and Cash Equivalents |
186 M | 442 M | 214 M | 191 M | 22.9 M | 97.3 M | 8.96 M | - | - | - | - | - | - |
Book Value |
573 M | 496 M | 229 M | 230 M | 140 M | 164 M | 1.48 M | -6.61 M | - | - | - | - | - |
Total Shareholders Equity |
573 M | 496 M | 229 M | 230 M | 140 M | 164 M | 1.33 M | -6.61 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Inspire Medical Systems
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
25.2 M | 24.5 M | 24.5 M | 24.8 M | 25.2 M | 22.1 M | 7.18 M | 7.54 M | 7.88 M | - | 24.5 M | 8.8 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.7 M | - | - | - | 24.6 M | - | - | - | 24.9 M | 24.8 M | 22 M | 24.9 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
99.6 M | 90.3 M | 96.8 M | 104 M | 95.3 M | 88.9 M | 67.2 M | 68.9 M | 57.3 M | - | 64.7 M | 66 M | 58.6 M | 52.3 M | 50.3 M | 51.4 M | 51.4 M | 51.4 M | 51.4 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | 36.1 M | 36.1 M | 36.1 M | 36.1 M | 23.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-327 M | -346 M | -355 M | -345 M | -360 M | -352 M | -340 M | -324 M | -327 M | - | -296 M | -279 M | -277 M | -267 M | -254 M | -237 M | -237 M | -237 M | -237 M | -180 M | -180 M | -180 M | -180 M | -147 M | -147 M | -147 M | -147 M | -125 M | -125 M | -125 M | -125 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
796 M | 728 M | 686 M | 677 M | 639 M | 618 M | 572 M | 565 M | 528 M | - | 290 M | 295 M | 279 M | 272 M | 273 M | 281 M | 281 M | 281 M | 281 M | 181 M | 181 M | 181 M | 181 M | 200 M | 200 M | 200 M | 200 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
148 M | 188 M | 175 M | 186 M | 330 M | 467 M | 442 M | 442 M | 418 M | 187 M | 203 M | 214 M | 210 M | 177 M | 182 M | 191 M | 191 M | 191 M | 191 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 97.3 M | 97.3 M | 97.3 M | 97.3 M | 8.96 M | 8.96 M | 8.96 M | 8.96 M | 6.68 M | - | - | - | 12.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
697 M | 638 M | 589 M | 573 M | 544 M | 529 M | 505 M | 496 M | 470 M | - | 225 M | 229 M | 220 M | 220 M | 223 M | 230 M | 230 M | 230 M | 230 M | 140 M | 140 M | 140 M | 140 M | 164 M | 164 M | 164 M | 164 M | 1.33 M | 25.1 M | 25.1 M | 25.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
697 M | 638 M | 589 M | 573 M | 544 M | 529 M | 505 M | 496 M | 470 M | 227 M | 225 M | 229 M | 220 M | 220 M | 223 M | 230 M | 230 M | 230 M | 230 M | 140 M | 140 M | 140 M | 140 M | 164 M | 164 M | 164 M | 164 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | -6.61 M | - | - | - | -1.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency